Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Benjamin Bitler

Concepts (419)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
53
2026
604
14.030
Why?
Poly(ADP-ribose) Polymerase Inhibitors
17
2026
139
5.690
Why?
Cystadenocarcinoma, Serous
9
2026
90
3.990
Why?
Claudin-4
5
2025
18
2.910
Why?
Drug Resistance, Neoplasm
15
2026
893
2.630
Why?
Genomic Instability
3
2025
64
2.480
Why?
Cell Line, Tumor
46
2026
3545
2.450
Why?
Phthalazines
6
2026
64
2.380
Why?
Histone-Lysine N-Methyltransferase
4
2024
141
2.150
Why?
Tumor Microenvironment
14
2026
747
2.070
Why?
Piperazines
6
2026
368
2.060
Why?
Fallopian Tubes
3
2024
33
1.630
Why?
Xenograft Model Antitumor Assays
11
2026
930
1.570
Why?
Gene Expression Regulation, Neoplastic
23
2026
1432
1.530
Why?
Nuclear Proteins
10
2018
740
1.450
Why?
Transcription Factors
13
2023
1730
1.360
Why?
Polycomb Repressive Complex 1
4
2026
65
1.220
Why?
Cellular Senescence
8
2026
225
1.150
Why?
Antineoplastic Agents
8
2026
2219
1.070
Why?
Poly(ADP-ribose) Polymerases
4
2026
88
1.040
Why?
beta Catenin
4
2025
250
1.020
Why?
Mice
37
2026
18297
0.990
Why?
Cell Proliferation
13
2026
2502
0.990
Why?
Tumor Escape
2
2025
50
0.930
Why?
BRCA2 Protein
6
2026
69
0.930
Why?
Female
70
2026
79499
0.920
Why?
Immune Evasion
1
2025
64
0.880
Why?
Autophagy
2
2024
290
0.860
Why?
Tryptophan Oxygenase
2
2024
33
0.860
Why?
Animals
50
2026
38107
0.830
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2025
1998
0.790
Why?
Histocompatibility Antigens
2
2024
102
0.780
Why?
Neoplasms
6
2023
2954
0.750
Why?
Humans
86
2026
146342
0.750
Why?
Mucin-1
4
2012
29
0.750
Why?
Wnt Signaling Pathway
5
2025
211
0.730
Why?
Ovary
2
2022
236
0.730
Why?
Indoles
4
2025
511
0.710
Why?
Protein-Arginine N-Methyltransferases
2
2019
25
0.700
Why?
DNA-Binding Proteins
9
2020
1468
0.690
Why?
Neoplasms, Cystic, Mucinous, and Serous
2
2021
27
0.680
Why?
Mutation
11
2026
4093
0.680
Why?
Breast Neoplasms
6
2024
2418
0.680
Why?
DNA Repair
6
2026
255
0.680
Why?
Neoplasms, Glandular and Epithelial
4
2018
52
0.670
Why?
Ascites
1
2021
48
0.650
Why?
Up-Regulation
5
2020
841
0.640
Why?
ErbB Receptors
5
2024
636
0.640
Why?
Programmed Cell Death 1 Receptor
1
2022
268
0.640
Why?
Epoxy Compounds
1
2020
31
0.620
Why?
Genomics
2
2024
853
0.620
Why?
Cytoreduction Surgical Procedures
1
2020
69
0.610
Why?
Endometrial Neoplasms
4
2025
205
0.610
Why?
Carnitine O-Palmitoyltransferase
1
2020
49
0.610
Why?
Rad51 Recombinase
1
2019
15
0.600
Why?
Azepines
4
2026
104
0.590
Why?
Chemotherapy, Adjuvant
1
2020
429
0.570
Why?
Metabolomics
1
2024
738
0.560
Why?
CD8-Positive T-Lymphocytes
1
2024
931
0.550
Why?
Signal Transduction
10
2024
5246
0.540
Why?
Proteomics
1
2024
1203
0.520
Why?
Membrane Proteins
4
2019
1130
0.510
Why?
Polycomb Repressive Complex 2
3
2015
79
0.510
Why?
Neoadjuvant Therapy
1
2020
475
0.500
Why?
Pyridones
2
2018
210
0.500
Why?
Poly (ADP-Ribose) Polymerase-1
3
2026
55
0.490
Why?
Histones
4
2026
670
0.490
Why?
Disease Progression
10
2026
2867
0.490
Why?
Fatty Acids
1
2020
460
0.490
Why?
Wnt Proteins
2
2021
131
0.470
Why?
Biomarkers, Tumor
6
2025
1339
0.470
Why?
Tumor Suppressor Protein p53
5
2026
530
0.460
Why?
Enhancer of Zeste Homolog 2 Protein
6
2020
55
0.460
Why?
Histone Deacetylases
1
2017
208
0.460
Why?
Cell Nucleus
3
2025
584
0.460
Why?
DNA Breaks, Double-Stranded
2
2026
55
0.430
Why?
B7-H1 Antigen
3
2024
245
0.430
Why?
Methyltransferases
1
2015
74
0.410
Why?
Cell Survival
4
2026
1105
0.410
Why?
Protein Kinase Inhibitors
2
2026
983
0.390
Why?
Molecular Targeted Therapy
2
2021
447
0.390
Why?
Anoikis
3
2023
30
0.390
Why?
Peptides
3
2023
992
0.370
Why?
Tryptophan
2
2024
184
0.370
Why?
Biological Assay
1
2013
133
0.370
Why?
Proto-Oncogene Proteins c-akt
1
2015
441
0.370
Why?
Small Molecule Libraries
1
2013
113
0.350
Why?
Gene Expression Profiling
6
2023
1792
0.340
Why?
Triazoles
3
2017
190
0.330
Why?
Carcinogenesis
3
2024
226
0.330
Why?
Apoptosis
6
2024
2439
0.310
Why?
Cells
1
2010
24
0.310
Why?
Mice, Transgenic
6
2024
2134
0.310
Why?
Inflammation
2
2023
2919
0.300
Why?
Neoplasm Invasiveness
2
2024
504
0.300
Why?
Alternative Splicing
2
2024
253
0.300
Why?
Neoplasm Grading
5
2024
313
0.300
Why?
Cisplatin
3
2026
347
0.280
Why?
DNA End-Joining Repair
2
2026
22
0.280
Why?
DNA Damage
5
2026
439
0.280
Why?
Transcriptome
3
2024
1068
0.280
Why?
Neoplasm Recurrence, Local
3
2025
1160
0.280
Why?
BRCA1 Protein
3
2021
84
0.270
Why?
Carcinoma
1
2010
225
0.270
Why?
Proto-Oncogene Proteins
1
2011
616
0.270
Why?
RNA, Small Interfering
5
2020
633
0.260
Why?
Piperidines
2
2019
225
0.260
Why?
Fibroblasts
1
2013
1034
0.260
Why?
Rad52 DNA Repair and Recombination Protein
1
2026
2
0.250
Why?
Drug Synergism
2
2025
354
0.250
Why?
E1A-Associated p300 Protein
1
2026
15
0.240
Why?
Drug Delivery Systems
1
2010
377
0.240
Why?
Receptors, Interleukin-8B
1
2026
29
0.240
Why?
Ketoglutaric Acids
1
2026
23
0.240
Why?
Aurora Kinase A
1
2026
57
0.240
Why?
Peptide Fragments
1
2010
693
0.240
Why?
Histone Deacetylase Inhibitors
2
2018
219
0.230
Why?
Carnitine
1
2026
91
0.230
Why?
Oncogenes
2
2019
113
0.230
Why?
Imidazoles
2
2024
245
0.220
Why?
Cell Cycle
3
2025
595
0.220
Why?
Receptor, Interferon alpha-beta
1
2024
35
0.210
Why?
Prognosis
3
2024
4351
0.210
Why?
Micronuclei, Chromosome-Defective
1
2024
9
0.210
Why?
Amino Acid Transport System ASC
1
2024
12
0.210
Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
1
2024
56
0.210
Why?
Estrogen Receptor alpha
1
2026
154
0.210
Why?
Minor Histocompatibility Antigens
1
2024
47
0.200
Why?
Ligands
2
2024
678
0.200
Why?
Cytotoxicity, Immunologic
1
2024
224
0.200
Why?
Endogenous Retroviruses
1
2024
37
0.200
Why?
DNA Transposable Elements
1
2024
125
0.200
Why?
Wnt4 Protein
2
2024
19
0.200
Why?
Repressor Proteins
2
2018
430
0.200
Why?
Lysine
2
2023
303
0.200
Why?
Aldehyde Dehydrogenase
2
2016
98
0.200
Why?
Exons
1
2024
361
0.200
Why?
Chromatin
3
2025
559
0.190
Why?
Polycomb-Group Proteins
1
2023
36
0.190
Why?
Lymphocytes, Tumor-Infiltrating
2
2021
156
0.190
Why?
Kynurenine
1
2024
114
0.190
Why?
Activating Transcription Factor 6
1
2023
19
0.190
Why?
Retinoblastoma-Binding Protein 2
1
2022
4
0.190
Why?
Cell Movement
3
2018
951
0.180
Why?
Transcription Factor AP-1
1
2023
76
0.180
Why?
Pyrimidines
1
2026
532
0.180
Why?
Indazoles
2
2021
86
0.180
Why?
Cell Cycle Checkpoints
4
2019
97
0.180
Why?
Down-Regulation
4
2022
614
0.180
Why?
X-ray Repair Cross Complementing Protein 1
1
2022
14
0.180
Why?
Genital Neoplasms, Female
1
2024
100
0.180
Why?
Acetylation
2
2026
262
0.180
Why?
Tumor Cells, Cultured
3
2019
882
0.180
Why?
Tripartite Motif-Containing Protein 28
1
2021
15
0.170
Why?
Carcinoma, Endometrioid
1
2022
49
0.170
Why?
Triple Negative Breast Neoplasms
1
2024
220
0.170
Why?
Granulosa Cells
1
2021
37
0.170
Why?
Antigen Presentation
1
2022
209
0.170
Why?
Killer Cells, Natural
1
2024
481
0.170
Why?
Single-Cell Analysis
1
2024
370
0.170
Why?
RNA Interference
3
2019
472
0.170
Why?
Transfection
3
2021
916
0.170
Why?
Epigenomics
1
2021
124
0.160
Why?
Promoter Regions, Genetic
3
2017
1242
0.160
Why?
Proteins
2
2017
1022
0.160
Why?
Ovarian Follicle
1
2021
78
0.160
Why?
Gene Knockdown Techniques
2
2020
335
0.160
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2021
87
0.160
Why?
Enzyme Inhibitors
1
2024
823
0.160
Why?
Cell Culture Techniques
2
2020
371
0.160
Why?
Macrophages
3
2024
1532
0.160
Why?
Immunity
2
2022
141
0.160
Why?
Lipids
1
2025
714
0.150
Why?
Early Detection of Cancer
1
2025
506
0.150
Why?
Wnt3A Protein
1
2019
11
0.150
Why?
Neoplasm Transplantation
2
2011
238
0.150
Why?
Computational Biology
1
2024
678
0.150
Why?
Germ-Line Mutation
1
2021
180
0.150
Why?
Interleukin-6
1
2024
784
0.150
Why?
Transcription, Genetic
4
2024
1432
0.150
Why?
Immunotherapy
2
2021
671
0.150
Why?
Immunity, Innate
2
2024
844
0.150
Why?
Acyltransferases
1
2019
78
0.150
Why?
Gene Frequency
1
2021
496
0.150
Why?
Machine Learning
1
2025
594
0.150
Why?
Sequence Analysis, DNA
2
2021
771
0.150
Why?
Receptors, Adiponectin
1
2019
23
0.150
Why?
Diagnostic Imaging
1
2022
340
0.150
Why?
Amino Acid Sequence
4
2015
2092
0.150
Why?
E2F Transcription Factors
1
2019
65
0.140
Why?
NF-kappa B
1
2023
674
0.140
Why?
Image Processing, Computer-Assisted
1
2023
778
0.140
Why?
Isocitrate Dehydrogenase
1
2019
71
0.140
Why?
CA-125 Antigen
1
2018
13
0.140
Why?
Heterografts
1
2019
143
0.140
Why?
Chloride Channels
1
2018
33
0.140
Why?
Protein Processing, Post-Translational
2
2021
487
0.140
Why?
Survival Rate
2
2020
2092
0.140
Why?
RNA Splicing Factors
1
2018
66
0.140
Why?
Drug Repositioning
1
2018
41
0.130
Why?
Chromosomal Proteins, Non-Histone
1
2018
131
0.130
Why?
Mice, SCID
3
2018
360
0.130
Why?
Histone Deacetylase 6
1
2017
17
0.130
Why?
Antineoplastic Agents, Phytogenic
1
2019
178
0.130
Why?
Genetic Testing
1
2021
492
0.130
Why?
Paclitaxel
1
2019
260
0.130
Why?
Cell Cycle Proteins
4
2017
630
0.130
Why?
Combined Modality Therapy
1
2020
1271
0.130
Why?
Claudins
1
2017
23
0.130
Why?
Sequence Analysis, RNA
1
2019
441
0.130
Why?
HMGB2 Protein
1
2016
4
0.120
Why?
Uterine Cervical Neoplasms
1
2020
269
0.120
Why?
Secretory Pathway
1
2016
7
0.120
Why?
Mevalonic Acid
1
2016
12
0.120
Why?
Class I Phosphatidylinositol 3-Kinases
1
2017
111
0.120
Why?
Adenocarcinoma, Clear Cell
1
2016
14
0.120
Why?
Tight Junctions
1
2017
87
0.120
Why?
Heterochromatin
2
2016
68
0.120
Why?
Mass Spectrometry
1
2019
729
0.120
Why?
Mammary Glands, Animal
1
2017
124
0.120
Why?
RNA, Long Noncoding
1
2018
174
0.120
Why?
Gene Expression Regulation, Enzymologic
1
2017
266
0.120
Why?
Genetics, Population
2
2008
226
0.120
Why?
Intracellular Signaling Peptides and Proteins
2
2019
457
0.120
Why?
Oxidation-Reduction
1
2020
1075
0.120
Why?
Colorectal Neoplasms
1
2024
874
0.120
Why?
Mice, Nude
2
2015
668
0.120
Why?
Tumor Burden
1
2017
326
0.120
Why?
Neoplasm Metastasis
4
2026
693
0.110
Why?
Endopeptidases
1
2015
80
0.110
Why?
Genetic Loci
1
2016
273
0.110
Why?
Phosphatidylinositol 3-Kinases
1
2017
384
0.110
Why?
Biomarkers
2
2024
4340
0.110
Why?
Protein Binding
3
2026
2244
0.110
Why?
Oxidative Stress
1
2021
1369
0.100
Why?
Homologous Recombination
2
2026
38
0.100
Why?
Disease Models, Animal
2
2024
4580
0.100
Why?
T-Lymphocytes
1
2022
2012
0.100
Why?
Epithelial Cells
2
2017
1119
0.100
Why?
Oncogene Protein p21(ras)
1
2013
11
0.100
Why?
Pyrimidine Nucleotides
1
2013
3
0.100
Why?
Purine Nucleotides
1
2013
12
0.100
Why?
beta-Galactosidase
1
2013
73
0.100
Why?
CCAAT-Binding Factor
1
2013
4
0.100
Why?
Carcinoma, Non-Small-Cell Lung
1
2022
1195
0.090
Why?
Dose-Response Relationship, Drug
1
2017
2022
0.090
Why?
Tomography, X-Ray Computed
1
2023
2786
0.090
Why?
Primary Cell Culture
1
2013
173
0.090
Why?
Genes, Reporter
1
2013
275
0.090
Why?
Aged, 80 and over
2
2025
8391
0.090
Why?
Proto-Oncogene Proteins c-met
1
2012
76
0.090
Why?
Gene Expression Regulation, Developmental
1
2017
902
0.090
Why?
Aged
5
2025
26432
0.090
Why?
Genes, ras
1
2011
70
0.090
Why?
Mitosis
2
2026
195
0.090
Why?
RNA Helicases
1
2011
31
0.090
Why?
Proteome
1
2016
520
0.090
Why?
Wnt-5a Protein
1
2011
25
0.090
Why?
Middle Aged
6
2025
36619
0.080
Why?
Interferons
2
2024
186
0.080
Why?
Molecular Sequence Data
3
2015
2838
0.080
Why?
Golgi Apparatus
1
2011
99
0.080
Why?
Gene Flow
2
2008
91
0.080
Why?
Follow-Up Studies
1
2020
5439
0.080
Why?
Cell Line
4
2021
2814
0.080
Why?
AMP-Activated Protein Kinases
2
2024
193
0.080
Why?
Models, Biological
3
2019
1761
0.080
Why?
Gene Expression Regulation
3
2016
2599
0.080
Why?
Endosomes
1
2011
139
0.080
Why?
Cyclin D1
1
2010
64
0.080
Why?
Active Transport, Cell Nucleus
1
2010
120
0.080
Why?
Cloning, Molecular
1
2010
526
0.070
Why?
Arachnida
1
2008
5
0.070
Why?
Caenorhabditis elegans Proteins
1
2011
209
0.070
Why?
Lung Neoplasms
1
2022
2675
0.070
Why?
Mammary Neoplasms, Experimental
1
2009
61
0.070
Why?
HEK293 Cells
2
2024
750
0.070
Why?
Prostatic Neoplasms
1
2015
972
0.070
Why?
Cytoplasm
1
2009
253
0.070
Why?
Immunohistochemistry
2
2022
1712
0.070
Why?
Trans-Activators
1
2010
372
0.070
Why?
Transforming Growth Factor alpha
1
2007
45
0.060
Why?
Mammary Neoplasms, Animal
1
2007
35
0.060
Why?
Neoplasm Staging
1
2011
1488
0.060
Why?
Bayes Theorem
2
2026
426
0.060
Why?
Cactaceae
1
2006
5
0.060
Why?
Triatoma
1
2006
7
0.060
Why?
Acetyl Coenzyme A
1
2026
8
0.060
Why?
Protein Structure, Tertiary
1
2009
834
0.060
Why?
Mice, Inbred NOD
2
2018
598
0.060
Why?
Mixed Function Oxygenases
1
2026
43
0.060
Why?
Dioxygenases
1
2026
36
0.060
Why?
Phylogeny
2
2008
924
0.060
Why?
Molecular Docking Simulation
1
2026
121
0.060
Why?
Mice, Knockout
2
2026
3125
0.060
Why?
Phenylurea Compounds
1
2026
122
0.060
Why?
Fructose
1
2026
132
0.060
Why?
Acidosis
1
2026
105
0.060
Why?
Maintenance Chemotherapy
1
2025
41
0.060
Why?
Myeloid-Derived Suppressor Cells
1
2026
78
0.060
Why?
Drosophila
1
2006
168
0.050
Why?
Hydrogen-Ion Concentration
1
2026
534
0.050
Why?
Genetic Variation
2
2008
996
0.050
Why?
Evolution, Molecular
1
2008
502
0.050
Why?
Retinal Dehydrogenase
2
2016
27
0.050
Why?
Epigenesis, Genetic
2
2020
712
0.050
Why?
Protein Transport
2
2019
443
0.050
Why?
Antineoplastic Agents, Hormonal
1
2026
196
0.050
Why?
Carbonyl Reductase (NADPH)
1
2024
5
0.050
Why?
Mutation, Missense
1
2026
334
0.050
Why?
Signal-To-Noise Ratio
1
2023
71
0.050
Why?
Transcription Factor RelB
1
2023
3
0.050
Why?
Cytokine TWEAK
1
2023
2
0.050
Why?
Protein Isoforms
1
2024
391
0.050
Why?
Tumor Necrosis Factors
1
2023
10
0.050
Why?
TWEAK Receptor
1
2023
6
0.050
Why?
Enhancer Elements, Genetic
1
2024
190
0.050
Why?
Muscular Atrophy
1
2023
88
0.050
Why?
Artifacts
1
2023
143
0.050
Why?
Cachexia
1
2023
74
0.050
Why?
Recombinational DNA Repair
1
2022
19
0.050
Why?
Carboplatin
1
2023
168
0.050
Why?
Receptors, Tumor Necrosis Factor
1
2023
162
0.050
Why?
Oligonucleotide Array Sequence Analysis
2
2016
752
0.040
Why?
Estradiol
1
2026
517
0.040
Why?
Gene Regulatory Networks
1
2024
319
0.040
Why?
Eukaryotic Initiation Factor-2
1
2021
34
0.040
Why?
Heterocyclic Compounds, 3-Ring
1
2021
44
0.040
Why?
Cluster Analysis
1
2022
496
0.040
Why?
Open Reading Frames
1
2021
130
0.040
Why?
Neutrophils
1
2026
1133
0.040
Why?
Double-Blind Method
1
2025
2070
0.040
Why?
Cell Division
1
2021
736
0.040
Why?
Culture Media, Conditioned
1
2019
112
0.040
Why?
Disease Susceptibility
1
2021
339
0.040
Why?
Paracrine Communication
1
2019
67
0.040
Why?
Mice, Inbred C57BL
3
2018
6034
0.040
Why?
Chromatin Assembly and Disassembly
1
2020
109
0.040
Why?
Blotting, Western
2
2011
1177
0.040
Why?
Coculture Techniques
1
2019
245
0.040
Why?
Computer Simulation
1
2023
1014
0.040
Why?
Immunophenotyping
1
2020
324
0.040
Why?
DNA
1
2025
1421
0.030
Why?
Mechanistic Target of Rapamycin Complex 1
1
2019
141
0.030
Why?
Protein Biosynthesis
1
2021
449
0.030
Why?
Stem Cells
1
2023
613
0.030
Why?
Gene Amplification
1
2018
116
0.030
Why?
Flow Cytometry
1
2022
1163
0.030
Why?
Survival Analysis
1
2021
1378
0.030
Why?
Desert Climate
2
2008
15
0.030
Why?
Aniline Compounds
1
2018
120
0.030
Why?
Recurrence
1
2021
1133
0.030
Why?
Arizona
2
2008
81
0.030
Why?
Case-Control Studies
1
2025
3647
0.030
Why?
Receptors, G-Protein-Coupled
1
2019
233
0.030
Why?
DNA Helicases
1
2018
138
0.030
Why?
Mexico
2
2008
233
0.030
Why?
Disease Management
1
2021
651
0.030
Why?
Phosphorylation
1
2021
1724
0.030
Why?
Pyridines
1
2021
610
0.030
Why?
Epithelial-Mesenchymal Transition
1
2018
219
0.030
Why?
Tumor Necrosis Factor-alpha
1
2021
1224
0.030
Why?
DNA, Mitochondrial
2
2008
212
0.030
Why?
Gene Knockout Techniques
1
2016
122
0.030
Why?
Sumoylation
1
2015
18
0.030
Why?
Lactation
1
2017
193
0.030
Why?
Metabolic Networks and Pathways
1
2016
175
0.030
Why?
T-Lymphocytes, Cytotoxic
1
2016
180
0.030
Why?
Algorithms
1
2023
1849
0.030
Why?
Models, Genetic
2
2008
540
0.030
Why?
Proteolysis
1
2015
174
0.030
Why?
Gene Silencing
1
2015
200
0.030
Why?
Protein-Tyrosine Kinases
1
2017
429
0.030
Why?
Chromatography, Liquid
1
2016
453
0.030
Why?
Sulfonamides
1
2018
594
0.030
Why?
Mice, Inbred BALB C
1
2017
1244
0.030
Why?
E2F7 Transcription Factor
1
2013
1
0.020
Why?
Ribonucleoside Diphosphate Reductase
1
2013
6
0.020
Why?
Melanoma
1
2020
765
0.020
Why?
Nucleosides
1
2013
25
0.020
Why?
Muscle, Skeletal
1
2023
1818
0.020
Why?
Tandem Mass Spectrometry
1
2016
576
0.020
Why?
Cell Growth Processes
1
2013
47
0.020
Why?
Epidermal Growth Factor
1
2012
157
0.020
Why?
ras Proteins
1
2013
148
0.020
Why?
Fanconi Anemia Complementation Group Proteins
1
2011
7
0.020
Why?
Adult
2
2025
41087
0.020
Why?
Genes, BRCA1
1
2011
45
0.020
Why?
Sorting Nexins
1
2011
12
0.020
Why?
Chromatin Immunoprecipitation
1
2011
139
0.020
Why?
Two-Hybrid System Techniques
1
2011
59
0.020
Why?
Time Factors
2
2016
7109
0.020
Why?
Immunoprecipitation
1
2011
150
0.020
Why?
Proto-Oncogene Proteins B-raf
1
2013
231
0.020
Why?
Real-Time Polymerase Chain Reaction
1
2011
334
0.020
Why?
Endocytosis
1
2011
170
0.020
Why?
Protein Folding
1
2011
281
0.020
Why?
HeLa Cells
1
2011
636
0.020
Why?
Cell Transformation, Neoplastic
1
2011
314
0.020
Why?
Recombinant Fusion Proteins
1
2011
663
0.020
Why?
Geography
1
2008
187
0.020
Why?
Phenotype
1
2016
3206
0.020
Why?
Population Dynamics
1
2008
142
0.020
Why?
Cells, Cultured
1
2015
4118
0.020
Why?
Caenorhabditis elegans
1
2011
330
0.020
Why?
Genes, Insect
1
2006
22
0.020
Why?
Haplotypes
1
2008
506
0.020
Why?
Cytochromes b
1
2006
13
0.020
Why?
Electron Transport Complex IV
1
2006
61
0.010
Why?
Insect Vectors
1
2006
39
0.010
Why?
Chagas Disease
1
2006
41
0.010
Why?
Host-Parasite Interactions
1
2006
109
0.010
Why?
Lymphoma
1
2007
251
0.010
Why?
Pregnancy
1
2017
7230
0.010
Why?
RNA, Messenger
1
2011
2791
0.010
Why?
Firefly Luciferin
1
1957
1
0.010
Why?
Diptera
1
1957
31
0.010
Why?
Luciferases
1
1957
153
0.010
Why?
Male
1
2015
73396
0.000
Why?
Bitler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)